The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study

The Lancet Respiratory Medicine

Volumn 5, Issue 8, 2017, Pages 639-647

  Ley, Brett ^a   Newton, Chad A ^b   Arnould, Isabel ^a   Elicker, Brett M ^a   Henry, Travis S ^a   Vittinghoff, Eric ^a   Golden, Jeffrey A ^a   Jones, Kirk D ^a   Batra, Kiran ^c   Torrealba, Jose ^c   Garcia, Christine Kim ^b   Wolters, Paul J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN 5B; MUC5B PROTEIN, HUMAN; SIGNAL PEPTIDE; TOLLIP PROTEIN, HUMAN;

ADULT; ALLERGIC PNEUMONITIS; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FIBROSING ALVEOLITIS; GENE; GENOMICS; HISTOPATHOLOGY; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUC5B GENE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; TELOMERE LENGTH; THORAX RADIOGRAPHY; TOLLIP GENE; AGED; BLOOD; CALIFORNIA; CASE CONTROL STUDY; CAUCASIAN; CLINICAL TRIAL; GENETICS; MORTALITY; MULTICENTER STUDY; TELOMERE; TEXAS;

AGED; ALVEOLITIS, EXTRINSIC ALLERGIC; CALIFORNIA; CASE-CONTROL STUDIES; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MUCIN-5B; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; TELOMERE; TEXAS;

EID: 85021185879     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(17)30216-3     Document Type: Article

References (48)

1. Selman, M, Pardo, A, King, TE Jr, Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am J Respir Crit Care Med 186 (2012), 314–324.
2. Mooney, JJ, Elicker, BM, Urbania, TH, et al. Radiographic fibrosis score predicts survival in hypersensitivity pneumonitis. Chest 144 (2013), 586–592.
3. Kern, RM, Singer, JP, Koth, L, et al. Lung transplantation for hypersensitivity pneumonitis. Chest 147 (2015), 1558–1565.
4. Christensen, LT, Schmidt, CD, Robbins, L, Pigeon breeders' disease—a prevalence study and review. Clin Allergy 5 (1975), 417–430.
5. Dalphin, JC, Debieuvre, D, Pernet, D, et al. Prevalence and risk factors for chronic bronchitis and farmer's lung in French dairy farmers. Br J Ind Med 50 (1993), 941–944.
6. Hendrick, DJ, Faux, JA, Marshall, R, Budgerigar-fancier's lung: the commonest variety of allergic alveolitis in Britain. BMJ 2 (1978), 81–84.
7. Lalancette, M, Carrier, G, Laviolette, M, et al. Farmer's lung. Long-term outcome and lack of predictive value of bronchoalveolar lavage fibrosing factors. Am Rev Respir Dis 148 (1993), 216–221.
8. Noth, I, Zhang, Y, Ma, SF, et al. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study. Lancet Respir Med 1 (2013), 309–317.
9. Peljto, AL, Zhang, Y, Fingerlin, TE, et al. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA 309 (2013), 2232–2239.
10. Seibold, MA, Wise, AL, Speer, MC, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 364 (2011), 1503–1512.
11. Fingerlin, TE, Murphy, E, Zhang, W, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet 45 (2013), 613–620.
12. Zhang, Y, Noth, I, Garcia, JG, Kaminski, N, A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis. N Engl J Med 364 (2011), 1576–1577.
13. Alder, JK, Stanley, SE, Wagner, CL, Hamilton, M, Hanumanthu, VS, Armanios, M, Exome sequencing identifies mutant TINF2 in a family with pulmonary fibrosis. Chest 147 (2015), 1361–1368.
14. Armanios, MY, Chen, JJ, Cogan, JD, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 356 (2007), 1317–1326.
15. Diaz de Leon, A, Cronkhite, JT, Katzenstein, AL, et al. Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS One, 5, 2010, e10680.
16. Kannengiesser, C, Borie, R, Menard, C, et al. Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis. Eur Respir J 46 (2015), 474–485.
17. Kropski, JA, Mitchell, DB, Markin, C, et al. A novel dyskerin (DKC1) mutation is associated with familial interstitial pneumonia. Chest 146 (2014), e1–e7.
18. Tsakiri, KD, Cronkhite, JT, Kuan, PJ, et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci USA 104 (2007), 7552–7557.
19. Stuart, BD, Choi, J, Zaidi, S, et al. Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening. Nat Genet 47 (2015), 512–517.
20. Stuart, BD, Lee, JS, Kozlitina, J, et al. Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation. Lancet Respir Med 2 (2014), 557–565.
21. Newton, CA, Batra, K, Torrealba, J, et al. Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive. Eur Respir J 48 (2016), 1710–1720.
22. Raghu, G, Collard, HR, Egan, JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183 (2011), 788–824.
23. Travis, WD, Costabel, U, Hansell, DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188 (2013), 733–748.
24. Silva, CI, Churg, A, Muller, NL, Hypersensitivity pneumonitis: spectrum of high-resolution CT and pathologic findings. AJR Am J Roentgenol 188 (2007), 334–344.
25. Silva, CI, Muller, NL, Lynch, DA, et al. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 246 (2008), 288–297.
26. Akashi, T, Takemura, T, Ando, N, et al. Histopathologic analysis of sixteen autopsy cases of chronic hypersensitivity pneumonitis and comparison with idiopathic pulmonary fibrosis/usual interstitial pneumonia. Am J Clin Pathol 131 (2009), 405–415.
27. Churg, A, Muller, NL, Flint, J, Wright, JL, Chronic hypersensitivity pneumonitis. Am J Surg Pathol 30 (2006), 201–208.
28. Churg, A, Sin, DD, Everett, D, Brown, K, Cool, C, Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol 33 (2009), 1765–1770.
29. 1000 Genomes Project Consortium, Auton, A, Brooks, LD, et al. A global reference for human genetic variation. Nature 526 (2015), 68–74.
30. Cronkhite, JT, Xing, C, Raghu, G, et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med 178 (2008), 729–737.
31. Best, AC, Meng, J, Lynch, AM, et al. Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality. Radiology 246 (2008), 935–940.
32. Hansell, DM, Bankier, AA, MacMahon, H, McLoud, TC, Muller, NL, Remy, J, Fleischner Society: glossary of terms for thoracic imaging. Radiology 246 (2008), 697–722.
33. Benjamini, Y, Hochberg, Y, Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 57 (1995), 289–300.
34. Hochberg, Y, A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75 (1988), 800–802.
35. Borie, R, Crestani, B, Dieude, P, et al. The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European caucasian population. PLoS One, 8, 2013, e70621.
36. Conti, C, Montero-Fernandez, A, Borg, E, et al. Mucins MUC5B and MUC5AC in distal airways and honeycomb spaces: comparison among idiopathic pulmonary fibrosis/usual interstitial pneumonia, fibrotic nonspecific interstitial pneumonitis, and control lungs. Am J Respir Crit Care Med 193 (2016), 462–464.
37. Nakano, Y, Yang, IV, Walts, AD, et al. MUC5B promoter variant rs35705950 affects MUC5B expression in the distal airways in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 193 (2016), 464–466.
38. Evans, CM, Fingerlin, TE, Schwarz, MI, et al. Idiopathic pulmonary fibrosis: a genetic disease that involves mucociliary dysfunction of the peripheral airways. Physiol Rev 96 (2016), 1567–1591.
39. Cogan, JD, Kropski, JA, Zhao, M, et al. Rare variants in RTEL1 are associated with familial interstitial pneumonia. Am J Respir Crit Care Med 191 (2015), 646–655.
40. Alder, JK, Chen, JJ, Lancaster, L, et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 105 (2008), 13051–13056.
41. Kropski, JA, Pritchett, JM, Zoz, DF, et al. Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease. Am J Respir Crit Care Med 191 (2015), 417–426.
42. Naikawadi, RP, Disayabutr, S, Mallavia, B, et al. Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis. JCI Insight, 1, 2016, e86704.
43. Povedano, JM, Martinez, P, Flores, JM, Mulero, F, Blasco, MA, Mice with pulmonary fibrosis driven by telomere dysfunction. Cell Rep 12 (2015), 286–299.
44. Okamoto, T, Miyazaki, Y, Tomita, M, Tamaoka, M, Inase, N, A familial history of pulmonary fibrosis in patients with chronic hypersensitivity pneumonitis. Respiration 85 (2013), 384–390.
45. Morell, F, Villar, A, Montero, MA, et al. Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study. Lancet Respir Med 1 (2013), 685–694.
46. Walsh, SL, Wells, AU, Desai, SR, et al. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study. Lancet Respir Med 4 (2016), 557–565.
47. Wong, JY, De Vivo, I, Lin, X, Fang, SC, Christiani, DC, The relationship between inflammatory biomarkers and telomere length in an occupational prospective cohort study. PLoS One, 9, 2014, e87348.
48. White, ES, Xia, M, Murray, S, et al. Plasma surfactant protein-D, matrix metalloproteinase-7, and osteopontin index distinguishes idiopathic pulmonary fibrosis from other idiopathic interstitial pneumonias. Am J Respir Crit Care Med 194 (2016), 1242–1251.